Sign In
Buy CDNA
$38.37
-1.36 (-3.42%)
At Close: Jul 20, 2026
Best Momentum Stocks to Buy for January 30th
11:16am, Thursday, 30'th Jan 2025
OBK, BBCP and CDNA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 30, 2024.
New Strong Buy Stocks for January 30th
07:50am, Thursday, 30'th Jan 2025
BBCP, SDVKY, OBK, CDNA and NVAX have been added to the Zacks Rank #1 (Strong Buy) List on January 30, 2024.
Is CareDx (CDNA) Outperforming Other Medical Stocks This Year?
10:41am, Wednesday, 29'th Jan 2025
Here is how CareDx (CDNA) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.
Best Momentum Stocks to Buy for January 21st
11:11am, Tuesday, 21'st Jan 2025
CDNA, AVXL and ALNY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 21, 2025.
New Strong Buy Stocks for January 21st
07:45am, Tuesday, 21'st Jan 2025
CDNA, ALNY, ICL, AVXL and AA have been added to the Zacks Rank #1 (Strong Buy) List on January 21, 2025.
Strength Seen in CareDx (CDNA): Can Its 6.1% Jump Turn into More Strength?
04:50am, Tuesday, 14'th Jan 2025
CareDx (CDNA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in t
CareDx Announces Preliminary Fourth Quarter and Full Year 2024 Results
07:00am, Monday, 13'th Jan 2025
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – today reported preliminary, unaudited financial results for the fourth quarter and full year ended Dece
CareDx: Top Of My Shopping List For 2025
01:23am, Wednesday, 25'th Dec 2024
CareDx is a promising candidate for the Bioreactor growth portfolio due to its leadership in transplant diagnostics and significant growth potential despite previous concerns. The company has shown st
CareDx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
07:05am, Wednesday, 18'th Dec 2024
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) - The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clin
TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy
07:00am, Wednesday, 11'th Dec 2024
EDINBURGH, Scotland , Dec. 11, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic ga
Has CareDx (CDNA) Outpaced Other Medical Stocks This Year?
10:45am, Tuesday, 03'rd Dec 2024
Here is how CareDx (CDNA) and Clover Health Investments, Corp. (CLOV) have performed compared to their sector so far this year.
Wall Street Analysts Predict a 49.89% Upside in CareDx (CDNA): Here's What You Should Know
10:56am, Monday, 25'th Nov 2024
The consensus price target hints at a 49.9% upside potential for CareDx (CDNA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate r
After Plunging -11.97% in 4 Weeks, Here's Why the Trend Might Reverse for CareDx (CDNA)
10:36am, Friday, 15'th Nov 2024
The heavy selling pressure might have exhausted for CareDx (CDNA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in
Are Medical Stocks Lagging CareDx (CDNA) This Year?
10:46am, Thursday, 14'th Nov 2024
Here is how CareDx (CDNA) and Doximity (DOCS) have performed compared to their sector so far this year.
CareDx to Participate in Upcoming Investor Conferences
07:05am, Tuesday, 12'th Nov 2024
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of cl
